Riverview Trust Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12
Closed -$1.25K 850
2024
Q3
$1.25K Buy
+12
New +$1.22K ﹤0.01% 613
2022
Q4
Sell
-495
Closed -$35K 737
2022
Q3
$35K Hold
495
0.03% 253
2022
Q2
$40K Hold
495
0.03% 239
2022
Q1
$38K Buy
+495
New +$39.2K 0.03% 255
2020
Q3
Sell
-200
Closed -$15K 247
2020
Q2
$15K Hold
200
0.01% 216
2020
Q1
$13K Buy
+200
New +$14.1K 0.01% 225
2019
Q4
Sell
-41
Closed -$3K 272
2019
Q3
$3K Hold
41
﹤0.01% 263
2019
Q2
$3K Sell
41
-171
-81% -$12.1K ﹤0.01% 257
2019
Q1
$15K Hold
212
0.01% 242
2018
Q4
$13K Buy
+212
New +$13.3K 0.01% 232

Other funds holding CL

Riverview Trust Company's CL Position: Q4 2024 in Review

Riverview Trust Company sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 12 shares — an estimated $1.25K sold.

Riverview Trust Company first reported a position in CL in Q4 2018 and held it in 10 quarters. The position peaked at $40K in Q2 2022. 1,932 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Riverview Trust Company reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • Riverview Trust Company sold 12 Colgate-Palmolive shares in Q4 2024, an estimated $1.25K.
  • Riverview Trust Company first reported a position in Colgate-Palmolive in Q4 2018 and held it in 10 quarters.
  • Riverview Trust Company's Colgate-Palmolive position peaked at $40K in Q2 2022.
  • 1,932 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Riverview Trust Company's 13F filing for Q4 2024, filed 6 Feb 2025.